You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

predictive%20biomarker

Showing 1 - 25 of 8,599
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Seoul (exosome and ctDNA evaluation)

Active, not recruiting
  • Triple Negative Breast Cancer
  • HER2-positive Breast Cancer
  • exosome and ctDNA evaluation
  • Seoul, Korea, Republic of
    Ji-Yeon Kim
Jul 13, 2023

Biofilm Composition asPredictive Biomarker for Prosthetic Joint

Completed
  • Joint Infection
  • Revision surgery
  • Portsmouth, Hampshire, United Kingdom
    Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital
Apr 6, 2023

Migraine Trial in Copenhagen (Calcitonin Gene-Related Peptide, Erenumab)

Recruiting
  • Migraine
  • Copenhagen, Glostrup, Denmark
    Danish Headache Center
Oct 21, 2022

Tumor Neck Trial in Shanghai (docetaxel, cisplatin and 5-fluorouracil)

Recruiting
  • Neoplasm Neck
  • docetaxel, cisplatin and 5-fluorouracil
  • Shanghai, Shanghai, China
    Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong
Oct 5, 2022

Rheumatoid Arthritis Trial in Clermont-Ferrand (Blood test)

Not yet recruiting
  • Rheumatoid Arthritis
  • Blood test
  • Clermont-Ferrand, France
    CHU Clermont-Ferrand
Sep 20, 2022

Mass Accumulation Rate asPredictive Biomarker in Multiple

Recruiting
  • Multiple Myeloma in Relapse
    • Duarte, California
    • +5 more
    Jul 13, 2022

    Metastatic Relapse in Triple Negative Breast Cancer Patients

    Recruiting
    • Triple Negative Breast Cancer
      • Clermont-Ferrand, France
        Centre Jean PERRIN
      Jan 12, 2022

      Fatty Liver Trial in Naples

      Completed
      • Fatty Liver
        • Naples, Italy
          University of Campania Luigi Vanvitelli
        Mar 27, 2023

        Memory Complaint, Alzheimer, Phosphorylated Metabolism Profile Trial in Poitiers (Additional sequence performed during MRI scan)

        Active, not recruiting
        • Memory Complaint
        • +3 more
        • Additional sequence performed during MRI scan
        • Poitiers, France
          CHU of Poitiers
        Nov 26, 2021

        Tislelizumab, Safety, Biomarker Trial in Guangzhou, Jiangmen (Tislelizumab 200 mg, Carboplatin AUC 5, pemetrexed 500mg/m2)

        Recruiting
        • Tislelizumab
        • +3 more
        • Tislelizumab 200 mg
        • +4 more
        • Guangzhou, Guangdong, China
        • +3 more
        Feb 8, 2022

        Anti-PD-1 Antibody Combined With Chemotherapy for Neoadjuvant

        Active, not recruiting
        • Locally Advanced Gastric Adenocarcinoma
        • PD-1
        • DNA panel and RNA Sequencing
        • Xi'an, Shaanxi, China
          Xijing Hospital of Digestive Diseases
        Aug 17, 2022

        Pain Trial in Baltimore (Painful Stimuli)

        Completed
        Has Results
        • Pain
        • Painful Stimuli
        • Baltimore, Maryland
          University of Maryland School of Dentistry
        Jul 19, 2021

        Checkpoint Inhibitor Response

        Active, not recruiting
        • NSCLC
        • +4 more
        • Breathprint analysis and patient-reported outcomes
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Centre
        Feb 24, 2022

        Meningioma, Meningioma Atypical, Anaplastic Meningioma Trial in Rome (Biological biomarker assessment)

        Recruiting
        • Meningioma
        • +2 more
        • Biological biomarker assessment
        • Rome, Italy
          Fondazione Policlinico Universitario A. Gemelli IRCCS
        Mar 29, 2023

        Parkinson Disease Trial in Nantes, Rennes, Tours ([18F]DPA-714 PET scan)

        Recruiting
        • Parkinson Disease
        • [18F]DPA-714 PET scan
        • Nantes, France
        • +3 more
        Sep 17, 2021

        Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

        Recruiting
        • Lung Cancer
          • Shanghai, China
            Shanghai Chest Hospital
          Jul 20, 2023

          Gluten-free Diet in Difficult to Manage Nephrotic Syndrome:

          Completed
          • Nephrotic Syndrome
          • Implementation of a gluten-free diet
          • New York, New York
            New York University School of Medicine
          Jun 21, 2021

          Metastatic Cancer, Carcinoma, Adenocarcinoma Trial in Cleveland (18F-Clofarabine)

          Recruiting
          • Metastatic Cancer
          • +2 more
          • Cleveland, Ohio
            Cleveland Clinic, Case Comprehensive Cancer Center
          May 11, 2022

          sCD8, as a Novel Biomarker for Pancreatic Cancer

          Recruiting
          • Serum Biomarker
          • Pancreatic Cancer
          • serum test
          • Beijing, Beijing, China
            Peking Union Medical College Hospital
          Aug 11, 2022

          FGFR Testing by Either ctDNA Blood Testing or Standard Tumor

          Recruiting
          • Metastatic Bladder Cancer
          • Metastatic Urothelial Carcinoma
          • FGFR Testing
          • Calgary, Alberta, Canada
          • +6 more
          Nov 8, 2023

          Melanoma Trial in Chapel Hill, Raleigh (FDG PET/CT scan, C11-AMT PET scan, Pembrolizumab)

          Active, not recruiting
          Has Results
          • Melanoma
          • FDG PET/CT scan
          • +3 more
          • Chapel Hill, North Carolina
          • +1 more
          Jan 10, 2023

          After Endoscopic Endonasal Pituitary Surgery

          Completed
          • Pituitary Adenoma
          • Endoscopic Endonasal Pituitary Surgery
          • Naples, Italy
            University of Naples "Federico II"
          May 3, 2021

          Panc CA Risk Model & Biomarker Testing In High-Risk Cohort

          Not yet recruiting
          • Pancreatic Adenocarcinoma
          • Blood Specimen
          • Boston, Massachusetts
            Beth Israel Deaconess Medical Center
          Sep 5, 2022

          ADAMTS-13 LEVEL AS PREDICTIVE BIOMARKER FOR DEVELOPMENT OF

          Unknown status
          • Liver Cirrhosis
            • Roma, Italy
              Raimondo De Cristofaro
            Nov 9, 2020

            TEWL Biomarker Study for Diabetic Foot Ulcer Recurrence

            Active, not recruiting
            • Diabetes
            • +4 more
            • Observational
            • San Francisco, California
            • +5 more
            Jan 20, 2023